Samsara Bio Capital, LLC Ngm Biopharmaceuticals Inc Transaction History

Samsara Bio Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.44 - $4.53 $33,352 - $61,920	-13,669 Closed	0 $0
Q1 2023 May 15, 2023	BUY	$3.72 - $5.4 $50,848 - $73,812	13,669 New	13,669 $55,000
Q3 2021 Nov 15, 2021	SELL	$20.15 - $26.19 $91,803 - $119,321	-4,556 Reduced 25.0%	13,669 $287,000
Q4 2020 Feb 17, 2021	SELL	$16.21 - $31.44 $295,443 - $573,025	-18,226 Reduced 50.0%	18,225 $552,000
Q3 2020 Nov 16, 2020	SELL	$15.59 - $19.97 $189,434 - $242,655	-12,151 Reduced 25.0%	36,451 $580,000
Q2 2020 Aug 14, 2020	BUY	$11.97 - $23.47 $581,765 - $1.14 Million	48,602 New	48,602 $959,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.